Hepatitis B immune globulin preparations and use in liver transplantation (Q35543573)

8 August 2017

1 reference

title

Hepatitis B immune globulin preparations and use in liver transplantation (English)

1 reference

8 August 2017

main subject

liver transplantation

1 reference

1 reference

2

Girish Vyas

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14509525

14 March 2024

author name string

Norah A. Terrault

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14509525

14 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14509525

14 March 2024

publication date

1 August 2003

1 reference

full work available at URL

8 August 2017

https://api.elsevier.com/content/article/PII:S108932610300045X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(03)00045-X

https://api.elsevier.com/content/article/PII:S108932610300045X?httpAccept=text/plain

14 March 2024

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(03)00045-X

14 March 2024

published in

Clinics in liver disease

1 reference

8 August 2017

volume

7

1 reference

8 August 2017

issue

3

1 reference

8 August 2017

page(s)

537-550

1 reference

Hepatitis B virus reinfection after orthotopic liver transplantation. Serological and clinical implications

8 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900045-X

7 January 2021

Liver transplantation in European patients with the hepatitis B surface antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900045-X

7 January 2021

Liver transplantation in HBs antigen (HBsAg) carriers. Prevention of hepatitis B virus (HBV) recurrence by passive immunization

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900045-X

7 January 2021

Passive immunoprophylaxis after liver transplantation in HBsAg-positive patients

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900045-X

7 January 2021

Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900045-X

7 January 2021

An efficacy and cost-effectiveness analysis of combination hepatitis B immune globulin and lamivudine to prevent recurrent hepatitis B after orthotopic liver transplantation compared with hepatitis B immune globulin monotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900045-X

7 January 2021

Prevention of recurrent hepatitis B post-liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900045-X

7 January 2021

Passive immunization against viral hepatitis – status and prospects

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900045-X

7 January 2021

Successful orthotopic liver transplantation for lamivudine-associated YMDD mutant hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900045-X

7 January 2021

Impact of immunoprophylaxis and patient selection on outcome of transplantation for HBsAg-positive liver recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900045-X

7 January 2021

Long-term follow-up of hepatitis B virus-infected recipients after orthotopic liver transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900045-X

7 January 2021

Improved outcome of orthotopic liver transplantation for chronic hepatitis B cirrhosis with aggressive passive immunization

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900045-X

7 January 2021

Increasing applicability of liver transplantation for patients with hepatitis B-related liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900045-X

7 January 2021

Combination low-dose hepatitis B immune globulin and lamivudine therapy provides effective prophylaxis against posttransplantation hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900045-X

7 January 2021

Persistent hepatitis B virus infection of mononuclear blood cells without concomitant liver infection. The liver transplantation model.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900045-X

7 January 2021

Hepatitis B virus envelope variation after transplantation with and without hepatitis B immune globulin prophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900045-X

7 January 2021

Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900045-X

7 January 2021

Incidence and clinical consequences of surface and polymerase gene mutations in liver transplant recipients on hepatitis B immunoglobulin.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900045-X

7 January 2021

Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900045-X

7 January 2021

Biology of hepatitis B virus.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900045-X

7 January 2021

Australia antigen (hepatitis B antigen): a conformational antigen dependent on disulfide bonds

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900045-X

7 January 2021

Immune response to synthetic peptide analogues of hepatitis B surface antigen specific for the a determinant

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900045-X

7 January 2021

Hepatitis B virus surface mutations associated with infection after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900045-X

7 January 2021

Efficacy of lamivudine in controlling hepatitis B virus recurrence after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900045-X

7 January 2021

A multicenter United States-Canadian trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900045-X

7 January 2021

Selection of hepatitis B virus polymerase mutants with enhanced replication by lamivudine treatment after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900045-X

7 January 2021

Restoration of replication phenotype of lamivudine-resistant hepatitis B virus mutants by compensatory changes in the "fingers" subdomain of the viral polymerase selected as a consequence of mutations in the overlapping S gene

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900045-X

7 January 2021

High-titered anti-HBs fresh frozen plasma for immunoprophylaxis against hepatitis B virus recurrence after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900045-X

7 January 2021

Genetic alterations in the gene encoding the major HBsAg: DNA and immunological analysis of recurrent HBsAg derived from monoclonal antibody-treated liver transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900045-X

7 January 2021

Preclinical evaluation of two human anti-hepatitis B virus (HBV) monoclonal antibodies in the HBV-trimera mouse model and in HBV chronic carrier chimpanzees

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900045-X

7 January 2021

Clinical evaluation (phase I) of a combination of two human monoclonal antibodies to HBV: safety and antiviral properties

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900045-X

7 January 2021

Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease

4

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(03)00045-X

Long-term passive immunoprophylaxis of B virus recurrence after liver transplantation in HBs antigen-positive patients

14 March 2024

16

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(03)00045-X

Recurrent HBV/HDV infections under different immunoprophylaxis protocols

14 March 2024

19

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(03)00045-X

14 March 2024

Identifiers

1 reference

8 August 2017

1 reference